CN1320617A - 一种新的多肽——人Pax蛋白14和编码这种多肽的多核苷酸 - Google Patents

一种新的多肽——人Pax蛋白14和编码这种多肽的多核苷酸 Download PDF

Info

Publication number
CN1320617A
CN1320617A CN00115454A CN00115454A CN1320617A CN 1320617 A CN1320617 A CN 1320617A CN 00115454 A CN00115454 A CN 00115454A CN 00115454 A CN00115454 A CN 00115454A CN 1320617 A CN1320617 A CN 1320617A
Authority
CN
China
Prior art keywords
polynucleotide
polypeptide
sequence
pax protein
human pax
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00115454A
Other languages
English (en)
Chinese (zh)
Inventor
毛裕民
谢毅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Biowindow Gene Development Inc
Original Assignee
Shanghai Biowindow Gene Development Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Biowindow Gene Development Inc filed Critical Shanghai Biowindow Gene Development Inc
Priority to CN00115454A priority Critical patent/CN1320617A/zh
Priority to PCT/CN2001/000606 priority patent/WO2001081399A1/fr
Priority to AU75631/01A priority patent/AU7563101A/en
Publication of CN1320617A publication Critical patent/CN1320617A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN00115454A 2000-04-27 2000-04-27 一种新的多肽——人Pax蛋白14和编码这种多肽的多核苷酸 Pending CN1320617A (zh)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN00115454A CN1320617A (zh) 2000-04-27 2000-04-27 一种新的多肽——人Pax蛋白14和编码这种多肽的多核苷酸
PCT/CN2001/000606 WO2001081399A1 (fr) 2000-04-27 2001-04-23 Nouveau polypeptide, proteine pax humaine 14, et polynucleotide codant pour ce polypeptide
AU75631/01A AU7563101A (en) 2000-04-27 2001-04-23 A novel polypeptide, a human pax protein 14 and the polynucleotide encoding the polypeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN00115454A CN1320617A (zh) 2000-04-27 2000-04-27 一种新的多肽——人Pax蛋白14和编码这种多肽的多核苷酸

Publications (1)

Publication Number Publication Date
CN1320617A true CN1320617A (zh) 2001-11-07

Family

ID=4584900

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00115454A Pending CN1320617A (zh) 2000-04-27 2000-04-27 一种新的多肽——人Pax蛋白14和编码这种多肽的多核苷酸

Country Status (3)

Country Link
CN (1) CN1320617A (fr)
AU (1) AU7563101A (fr)
WO (1) WO2001081399A1 (fr)

Also Published As

Publication number Publication date
WO2001081399A1 (fr) 2001-11-01
AU7563101A (en) 2001-11-07

Similar Documents

Publication Publication Date Title
CN1320616A (zh) 一种新的多肽——人Pax蛋白17和编码这种多肽的多核苷酸
CN1315442A (zh) 一种新的多肽——人细胞分化转录因子11和编码这种多肽的多核苷酸
CN1314401A (zh) 一种新的多肽——人调控转录因子8和编码这种多肽的多核苷酸
CN1314404A (zh) 一种新的多肽——人调控转录因子15和编码这种多肽的多核苷酸
CN1322755A (zh) 一种新的多肽——人Pax蛋白9和编码这种多肽的多核苷酸
CN1321664A (zh) 一种新的多肽——人Pax蛋白23和编码这种多肽的多核苷酸
CN1312259A (zh) 一种新的多肽——人Pax蛋白9和编码这种多肽的多核苷酸
CN1315433A (zh) 一种新的多肽——人细胞分化转录因子58和编码这种多肽的多核苷酸
CN1313399A (zh) 一种新的多肽——人信号肽酶15和编码这种多肽的多核苷酸
CN1320617A (zh) 一种新的多肽——人Pax蛋白14和编码这种多肽的多核苷酸
CN1320618A (zh) 一种新的多肽——人Pax蛋白12.5和编码这种多肽的多核苷酸
CN1320615A (zh) 一种新的多肽——人Pax蛋白16和编码这种多肽的多核苷酸
CN1315441A (zh) 一种新的多肽——人细胞分化转录因子14和编码这种多肽的多核苷酸
CN1314384A (zh) 一种新的多肽——人调控转录因子10和编码这种多肽的多核苷酸
CN1314386A (zh) 一种新的多肽——人调控转录因子31和编码这种多肽的多核苷酸
CN1315426A (zh) 一种新的多肽——人细胞分化转录因子8和编码这种多肽的多核苷酸
CN1315419A (zh) 一种新的多肽——人细胞分化转录因子13和编码这种多肽的多核苷酸
CN1321683A (zh) 一种新的多肽——人Pax蛋白10.1和编码这种多肽的多核苷酸
CN1320620A (zh) 一种新的多肽——人Pax蛋白19和编码这种多肽的多核苷酸
CN1314393A (zh) 一种新的多肽——人调控转录因子9. 7和编码这种多肽的多核苷酸
CN1314405A (zh) 一种新的多肽——人调控转录因子54和编码这种多肽的多核苷酸
CN1321680A (zh) 一种新的多肽——人Pax蛋白11.6和编码这种多肽的多核苷酸
CN1314400A (zh) 一种新的多肽——人调控转录因子9和编码这种多肽的多核苷酸
CN1321681A (zh) 一种新的多肽——人Pax蛋白11.3和编码这种多肽的多核苷酸
CN1314399A (zh) 一种新的多肽——人调控转录因子14和编码这种多肽的多核苷酸

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication